RUNX1 Is a Key Target in t(4;11) Leukemias that Contributes to Gene Activation through an AF4-MLL Complex Interaction
The Mixed Lineage Leukemia (MLL) protein is an important epigenetic regulator required for the maintenance of gene activation during development. MLL chromosomal translocations produce novel fusion proteins that cause aggressive leukemias in humans. Individual MLL fusion proteins have distinct leuke...
Main Authors: | Wilkinson, A, Ballabio, E, Geng, H, North, P, Tapia, M, Kerry, J, Biswas, D, Roeder, R, Allis, C, Melnick, A, de Bruijn, M, Milne, T |
---|---|
格式: | Journal article |
出版: |
2013
|
相似書籍
-
RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction.
由: Wilkinson, A, et al.
出版: (2013) -
PAF1 and FACT cooperate with MLL-AF4 to drive enhancer activity in leukemia
由: Milne, T, et al.
出版: (2022) -
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia.
由: Kerry, J, et al.
出版: (2017) -
MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia
由: Crump, NT, et al.
出版: (2023) -
MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation.
由: Godfrey, L, et al.
出版: (2016)